Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and Outcomes
Pieter Martens1, Mazen Hanna2, Jason Valent3
1Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA; Department of Cardiology, Ziekenhuis Oost Limburg, Genk, Belgium and University Hasselt, Belgium.
Insights
Electrical dyssynchrony is common in cardiac amyloidosis (CA), particularly transthyretin CA (ATTR-CA). This condition is linked to poorer outcomes and increased need for pacemakers.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Amyloidosis Research
Background:
- Cardiac amyloidosis (CA) frequently involves the conduction system.
- The prevalence and impact of ventricular electrical dyssynchrony in CA are not well understood.
Purpose of the Study:
- To determine the frequency of electrical dyssynchrony in CA.
- To assess its clinical correlates and impact on patient outcomes.
- To compare the relationship between cardiac hypertrophy and QRS duration in CA versus non-CA patients.
Main Methods:
- Analysis of a prospectively maintained registry of CA patients.
- Definition of electrical dyssynchrony as QRS duration > 130 msec.
- Comparison with a QRS-matched cohort without CA using cardiac MRI.
Main Results:
- 20% of 1140 CA patients (39% AL, 61% TTR) had electrical dyssynchrony.
- ATTR-CA, older age, male gender, white race, and CAD were associated with dyssynchrony.
- Electrical dyssynchrony correlated with worse functional status and higher mortality/pacing indications.
Conclusions:
- Electrical dyssynchrony is prevalent in CA, especially ATTR-CA.
- It is associated with diminished functional capacity and adverse clinical outcomes.
- Further research is needed on optimal monitoring and pacing strategies for CA patients with dyssynchrony.
Background:
Conduction-system involvement in cardiac amyloidosis (CA) is common. The prevalence, clinical correlates and impact on outcome related to ventricular electrical dyssynchrony in CA remain insufficiently elucidated.
Methods:
Data from a prospectively maintained registry of patients with CA diagnosed in the Cleveland Clinic's amyloidosis clinic was used to determine the frequency of electrical dyssynchrony (defined as a QRS > 130 msec). The relation with the clinical profile and clinical outcome was assessed. To determine the impact of hypertrophy on QRS prolongation, a QRS-matched cohort without CA was used for comparison of cardiac magnetic resonance imaging.
Results:
A total of 1140 patients with CA (39% AL, 61% TTR) were evaluated, of whom 230 (20%) had electrical dyssynchrony. The type of conduction block was predominantly a right bundle branch block (BBB, 48%) followed by left BBB (35%) and intraventricular conduction delay (17%). Presence of transthyretin amyloidosis (ATTR-CA), older age, male gender, white race, and coronary artery disease were independently (P< 0.05 for all) associated with electrical dyssynchrony, and patients were more commonly prescribed a mineralocorticoid receptor antagonist. In ATTR-CA, specifically, every increase in ATTR-CA disease stage was associated with a 1.55-fold (1.23--1.95; P< 0.001) increased odds for electrical dyssynchrony. In a subset of patients with CA who underwent cardiac magnetic resonance imaging (n = 41), left ventricular mass index was unrelated to the QRS duration (r = 0.187; P = 0.283) in CA, in contrast to a non-CA QRS-matched cohort (r = 0.397; P< 0.001). Patients with electrical dyssynchrony were more symptomatic at initial presentation, as illustrated by a higher New York Heart Association class (P= 0.041). During a median follow-up of 462 days (IQR:138--996 days), a higher proportion of patients with electrical dyssynchrony died from all-cause death (P= 0.037) or developed a permanent pacing indication (3% vs 10.4%; P< 0.001) during follow-up.
Conclusion:
Electrical dyssynchrony is common in CA, especially in ATTR-CA, and is associated with worse functional status and clinical outcome. Given the high rate of permanent pacing indications at follow-up, additional studies are necessary to determine the best monitoring and pacing strategies in CA.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Mechanism of Cardiac Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy


